Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge

Vaccine

Volumn 29, Issue 2, 2010, Pages 274-282

  Branger, Christine G ^a   Sun, Wei ^a   Torres Escobar, Ascención ^a   Perry, Robert ^b   Roland, Kenneth L ^a   Fetherston, Jacqueline ^b   Curtiss, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

LcrV; Psn; Recombinant attenuated Salmonella vaccine; Yersinia pestis

Indexed keywords

AMINO ACID; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIOCIN; HEMOPROTEIN; HMUR PROTEIN; LCRV PROTEIN; PSN PROTEIN; SALMONELLOSIS VACCINE; SIDEROPHORE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; YERSINIABACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA; YERSINIA INFECTION; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; SALMONELLA VACCINES; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; YERSINIA PESTIS;

EID: 78649697669     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.033     Document Type: Article

References (51)

1. Bottone E.J. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997, 10(April (2)):257-276.
2. Perry R.D., Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997, 10(January (1)):35-66.
3. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 1998, 62(December (4)):1315-1352.
4. Sarker M.R., Neyt C., Stainier I., Cornelis G.R. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD. J Bacteriol 1998, 180(March (5)):1207-1214.
5. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003, 71(July (7)):3673-3681.
6. Abramov V.M., Khlebnikov V.S., Vasiliev A.M., Kosarev I.V., Vasilenko R.N., Kulikova N.L., et al. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. J Proteome Res 2007, 6(June (6)):2222-2231.
7. Reithmeier-Rost D., Bierschenk S., Filippova N., Schroder-Braunstein J., Sing A. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cell Immunol 2004, 231(September-October (1-2)):63-74.
8. Sing A., Roggenkamp A., Geiger A.M., Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 2002, 168(February (3)):1315-1321.
9. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., et al. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 2002, 196(October (8)):1017-1024.
10. Depaolo R.W., Tang F., Kim I., Han M., Levin N., Ciletti N., et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008, 4(October (4)):350-361.
11. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 1997, 65(February (2)):446-451.
12. Sing A., Reithmeier-Rost D., Granfors K., Hill J., Roggenkamp A., Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci USA 2005, 102(November (44)):16049-16054.
13. Motin V.L., Pokrovskaya M.S., Telepnev M.V., Kutyrev V.V., Vidyaeva N.A., Filippov A.A., et al. The difference in the lcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains. Microb Pathog 1992, 12(March (3)):165-175.
14. Rakin A., Urbitsch P., Heesemann J. Evidence for two evolutionary lineages of highly pathogenic Yersinia species. J Bacteriol 1995, 177(May (9)):2292-2298.
15. Perry R.D., Shah J., Bearden S.W., Thompson J.M., Fetherston J.D. Yersinia pestis TonB: role in iron, heme, and hemoprotein utilization. Infect Immun 2003, 71(July (7)):4159-4162.
16. Carniel E., Guilvout I., Prentice M. Characterization of a large chromosomal " high-pathogenicity island" in biotype 1B Yersinia enterocolitica. J Bacteriol 1996, 178(December (23)):6743-6751.
17. Fetherston J.D., Lillard J.W., Perry R.D. Analysis of the pesticin receptor from Yersinia pestis: role in iron-deficient growth and possible regulation by its siderophore. J Bacteriol 1995, 177(April (7)):1824-1833.
18. Bearden S.W., Fetherston J.D., Perry R.D. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun 1997, 65(May (5)):1659-1668.
19. Fetherston J.D., Kirillina O., Bobrov A.G., Paulley J.T., Perry R.D. The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun 2010, 78(May (5)):2045-2052.
20. Thompson J.M., Jones H.A., Perry R.D. Molecular characterization of the hemin uptake locus (hmu) from Yersinia pestis and analysis of hmu mutants for hemin and hemoprotein utilization. Infect Immun 1999, 67(August (8)):3879-3892.
21. Hornung J.M., Jones H.A., Perry R.D. The hmu locus of Yersinia pestis is essential for utilization of free haemin and haem-protein complexes as iron sources. Mol Microbiol 1996, 20(May (4)):725-739.
22. Rossi M.S., Fetherston J.D., Letoffe S., Carniel E., Perry R.D., Ghigo J.M. Identification and characterization of the hemophore-dependent heme acquisition system of Yersinia pestis. Infect Immun 2001, 69(November (11)):6707-6717.
23. Forman S., Paulley J.T., Fetherston J.D., Cheng Y.Q., Perry R.D. Yersinia ironomics: comparison of iron transporters among Yersinia pestis biotypes and its nearest neighbor, Yersinia pseudotuberculosis. Biometals 2010, 23(April (2)):275-294.
24. Germanier R., Fürer E. Isolation and characterization of galE mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975, 131(May (5)):553-558.
25. Curtiss R. Bacterial infectious disease control by vaccine development. J Clin Invest 2002, 110(October (8)):1061-1066.
26. Branger C.G., Fetherston J.D., Perry R.D., Curtiss R. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague. Adv Exp Med Biol 2007, 603:387-399.
27. Bollen W.S., Gunn B.M., Mo H., Lay M.K., Curtiss R. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun 2008, 76(July (7)):3268-3272.
28. Curtiss R., Wanda S.Y., Gunn B.M., Zhang X., Tinge S.A., Ananthnarayan V., et al. Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infect Immun 2009, 77(March (3)):1071-1082.
29. Li Y., Wang S., Scarpellini G., Gunn B., Xin W., Wanda S.Y., et al. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci USA 2009, 106(January (2)):593-598.
30. Li Y., Wang S., Xin W., Scarpellini G., Shi Z., Gunn B., et al. A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines. Infect Immun 2008, 76(November (11)):5238-5246.
31. Xin W., Wanda S.Y., Li Y., Wang S., Mo H., Curtiss R. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun 2008, 76(July (7)):3241-3254.
32. Gunn B.M., Wanda S.Y., Burshell D., Wang C., Curtiss R. Construction of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine vector strains for safety in newborn and infant mice. Clin Vaccine Immunol 2010, 17(March (3)):354-362.
33. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413(October (6855)):523-527.
34. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 1951, 62(September (3)):293-300.
35. Perry R.D., Pendrak M.L., Schuetze P. Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis. J Bacteriol 1990, 172(October (10)):5929-5937.
36. 2+ response operon encodes the V antigen of Yersinia pestis. Infect Immun 1986, 54(November (2)):428-434.
37. Kang H.Y., Srinivasan J., Curtiss R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 2002, 70(April (4)):1739-1749.
38. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(August (5259)):680-685.
39. Curtiss R., Charamella L.J., Berg C.M., Harris P.E. Kinetic and genetic analyses of d-cycloserine inhibition and resistance in Escherichia coli. J Bacteriol 1965, 90(November (5)):1238-1250.
40. Fields K.A., Nilles M.L., Cowan C., Straley S.C. Virulence role of V antigen of Yersinia pestis at the bacterial surface. Infect Immun 1999, 67(October (10)):5395-5408.
41. Branger C.G., Torres-Escobar A., Sun W., Perry R., Fetherston J., Roland K.L., et al. Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica. Vaccine 2009, 27(August (39)):5363-5370.
42. Fetherston J.D., Bearden S.W., Perry R.D. YbtA, an AraC-type regulator of the Yersinia pestis pesticin/yersiniabactin receptor. Mol Microbiol 1996, 22(October (2)):315-325.
43. Titball R.W., Williamson E.D. Vaccination against bubonic and pneumonic plague. Vaccine 2001, 19(July (30)):4175-4184.
44. Motin V.L., Nakajima R., Smirnov G.B., Brubaker R.R. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 1994, 62(October (10)):4192-4201.
45. Hill J., Leary S.E., Griffin K.F., Williamson E.D., Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 1997, 65(November (11)):4476-4482.
46. Overheim K.A., Depaolo R.W., Debord K.L., Morrin E.M., Anderson D.M., Green N.M., et al. LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 2005, 73(August (8)):5152-5159.
47. Nakajima R., Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993, 61(January (1)):23-31.
48. Pouliot K., Pan N., Wang S., Lu S., Lien E., Goguen J.D. Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun 2007, 75(July (7)):3571-3580.
49. Lathem W.W., Crosby S.D., Miller V.L., Goldman W.E. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci USA 2005, 102(December (49)):17786-17791.
50. Shi H., Santander J., Brenneman K.E., Wanda S.Y., Wang S., Senechal P., et al. Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen. PLoS One 2010, 5(6):e11142.
51. Induction of host immune responses using Salmonella-vectored vaccines 2007, ASM Press, Washington, DC. R. Curtiss, X. Zhang, S.Y. Wanda, H.Y. Kang, V. Konjufca, Y. Li (Eds.).